Martingale Asset Management L P Athira Pharma, Inc. Transaction History

Martingale Asset Management L P

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$2.74 - $13.43 $1,857 - $9,105	678 Added 1.72%	40,107 $122,000
Q1 2022 May 12, 2022	SELL	$8.96 - $13.51 $1,792 - $2,702	-200 Reduced 0.5%	39,429 $532,000
Q4 2021 Feb 11, 2022	BUY	$9.17 - $16.39 $206,590 - $369,250	22,529 Added 131.75%	39,629 $516,000
Q3 2021 Nov 12, 2021	BUY	$9.15 - $11.09 $156,465 - $189,639	17,100 New	17,100 $160,000

16.9M

112K

68K

Ticker ATHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,817,700
Market Cap $24.6M
Description
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. The company's lead product candidate is ATH-1017, a blood brain barrier-penetrating, small molecule HGF/MET positive modulator that is in LIFT-AD Phase 3 and ACT-AD Phase 2 clinical tri...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.